In this study, the CRP level of patients was improved after treatment, suggesting that the Chinese medicine antitumor formula has certain effects on the treatment of advanced renal cancer, and Ang, VEGF, and CRP can be considered as vital indicators to assess the disease progression in patients. The gene discussed is VEGFA; the disease is renal carcinoma.